1. Comparison of the incidence of osteoradionecrosis with conventional radiotherapy and intensity‐modulated radiotherapy. Issue 11 (31st May 2016) Authors: Maesschalck, Thibault De; Dulguerov, Nicolas; Caparrotti, Francesca; Scolozzi, Paolo; Picardi, Cristina; Mach, Nicolas; Koutsouvelis, Nikolaos; Dulguerov, Pavel Journal: Head & neck Issue: Volume 38:Issue 11(2016) Page Start: 1695 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II study. (October 2022) Authors: Addeo, Alfredo; Rothschild, Sacha I.; Holer, Lisa; Schneider, Martina; Waibel, Christine; Haefliger, Simon; Mark, Michael; Fernandez, Eugenio; Mach, Nicolas; Mauti, Laetitia; Jermann, Philip M.; Alborelli, Ilaria; Calgua, Byron; Savic-Prince, Spasenija; Joerger, Markus; Früh, Martin Journal: Lung cancer Issue: Volume 172(2022) Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies. (3rd August 2017) Authors: Migliorini, Denis; Mach, Nicolas; Aguiar, Diego; Vernet, Rémi; Landis, Basile Nicolas; Becker, Minerva; McKee, Thomas; Dutoit, Valérie; Dietrich, Pierre-Yves Journal: Oncoimmunology Issue: Volume 6:Number 8(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial. (July 2018) Authors: Siano, Marco; Espeli, Vittoria; Mach, Nicolas; Bossi, Paolo; Licitra, Lisa; Ghielmini, Michele; Frattini, Milo; Canevari, Silvana; De Cecco, Loris Journal: Oral oncology Issue: Volume 82(2018) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Giant Cell Tumor of Bone With Pseudosarcomatous Changes Leading to Premature Denosumab Therapy Interruption: A Case Report With Review of the Literature. (June 2016) Authors: Sanchez-Pareja, Andrea; Larousserie, Frédérique; Boudabbous, Sana; Beaulieu, Jean-Yves; Mach, Nicolas; Saiji, Essia; Rougemont, Anne-Laure Journal: International journal of surgical pathology Issue: Volume 24:Number 4(2016) Page Start: 366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer. (7th June 2017) Authors: Siano, Marco; Molinari, Francesca; Martin, Vittoria; Mach, Nicolas; Früh, Martin; Freguia, Stefania; Corradino, Irene; Ghielmini, Michele; Frattini, Milo; Espeli, Vittoria Journal: Oncologist Issue: Volume 22:Number 7(2017) Page Start: 782 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer. (July 2017) Authors: Siano, Marco; Molinari, Francesca; Martin, Vittoria; Mach, Nicolas; Früh, Martin; Freguia, Stefania; Corradino, Irene; Ghielmini, Michele; Frattini, Milo; Espeli, Vittoria Journal: Oncologist Issue: Volume 22:Number 7(2017) Page Start: 782 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P-190 Personalized Immunotherapy with Cell-Encapsulation Technology for 2nd line R/M HNSCC: Safety and Early Efficacy Data from all HNSCC patients treated with MVX-ONCO-1 in two clinical trials. (July 2021) Authors: Fernandez, Eugenio; Vernet, Remi; Charrier, Emily; Joerger, Markus; de Belkouch, Marie-Clau; Urwyler, Muriel; von Rohr, Olivier; Rubin, Olivier; Villard, Jean; Ancrenaz, Virginie; Grandjean, Nicole; Lavallière, Emmanuel; Lafferma, Elisabeth; Grogg, Julien; Mach, Nicolas Journal: Oral oncology Issue: Volume 118(2021)Supplement Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Issue 10167 (12th January 2019) Authors: Cohen, Ezra E W; Soulières, Denis; Le Tourneau, Christophe; Dinis, José; Licitra, Lisa; Ahn, Myung-Ju; Soria, Ainara; Machiels, Jean-Pascal; Mach, Nicolas; Mehra, Ranee; Burtness, Barbara; Zhang, Pingye; Cheng, Jonathan; Swaby, Ramona F; Harrington, Kevin J Journal: Lancet Issue: Volume 393:Issue 10167(2019) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040. (14th May 2020) Authors: Harrington, Kevin J; Soulières, Denis; Le Tourneau, Christophe; Dinis, Jose; Licitra, Lisa F; Ahn, Myung-Ju; Soria, Ainara; Machiels, Jean-Pascal H; Mach, Nicolas; Mehra, Ranee; Burtness, Barbara; Ellison, Misoo C; Cheng, Jonathan D; Chirovsky, Diana Romana; Swaby, Ramona F; Cohen, Ezra E W Journal: Journal of the National Cancer Institute Issue: Volume 113:Number 2(2021) Page Start: 171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗